In 1998, Sistemas Genómicos was created. The first Spanish firm and one of the first in Europe, to specialize in DNA sequencing. Since then, its whole activity has centered on improving on a daily basis. It is all effort and passion for science.
Very soon, the first fruits of this effort were seen. After only two years since its creation, the firm made history by participating in the first DNA sequencing of a plant organism: the Arabidopsis thaliana plant. This milestone permitted the firm to invest in better large-scale DNA sequencing technologies.
From 2000 to 2003, Sistemas Genómicos (SIG) opened up its field of action in the Agrofood sector. So it was that it centres on analysing transgenic foods and on offering its genetic food authentication service known as AutentiGen®. This service enabled the firm to once again write a page in the history of Spanish science as it became the first Spanish laboratory dedicated to analyse genetically modified organisms.
In 2003, the firm took a firm commitment in progress and research, opened its biomedical division, and addressed its studies to diagnose genetic diseases and to apply them to reproductive medicine. This was a significant advance in the prevention of hereditary diseases.
In 2005, the firm absorbed the whole of the Institut de Genética Mèdica i Molecular (IGEM – Institute of Medical and Molecular Genetics), specialized in medical genetics and prenatal diagnoses. In the same year, it participated in another milestone: the International Tomato Sequencing Project. This was the largest contribution to sequencing genomes done in our country.
In its eagerness to innovate and invest in new technologies, the firm acquired an ultra-sequencing platform. So in 2008, it became the Official Service Provider in Europe of this kind of services.
In 2010, it opened the Sistemas Genómicos Foundation.
Nowadays, Sistemas Genómicos occupies the leading position in DNA and RNA analyses in Spain and has the capability of successfully taking international genome sequencing.
projects.
SIG diversifies its services and products into three main areas:
- Human Genetics: specialised in the diagnosis of genetic diseases, in a high percentage considered to be rare diseases, the study of their physiopathological processes and the development of new treatment outlines that address personalised medicine.
- Agrogenomics: The Agrofood Unit has a team of highly qualified professionals to perform assays for the food and cosmetic industry. The aim here is to provide industry with the tools it needs in food safety matters. For this purpose, this unit has the best professionals and the most suitable technology.
- Research: As participants in a large number of national, international and European projects, we offer the most qualified scientists and the best techniques to design and carry out large-scale genomic and transcriptomic projects. We have the acknowledged capacity to collaborate with international consortia to match any development in the genome and transcriptome research field. Research is a global, transversal area in the company including different departments: Projects, New Technologies and Bioinformatics.
Regarding the market, Sistemas Genómicos sales volume in 2013 was 3.47 million euros and, during the last three years, the growth sales rate of the company is rising from 3-5% every year.
Originally a Spanish company focused in national market, from 2012 SIG is investing in the internationalization of its business. Our Sales team has increased through Europe and is principally targeting the French, Italian and UK markets with own-staff representatives in several countries.
The company is distributing also in Latin America (with headquarters in Mexico DF), North America, Canada (with headquarters in Toronto) and Saudi Arabia.
